Expert Panels To Offer Some Device Manufacturers Scientific Advice Under EU Pilot
Executive Summary
Manufacturers of high-risk class III medical devices and class IIb active medical devices that administer or remove medicinal products from the human body will be able to access expert panel advice prior to applying for CE-marking under a newly-announced European Medicines Agency pilot scheme.
You may also be interested in...
Manufacturers Can Now Apply For Clinical Advice Under EU Expert Panel Pilot
Manufacturers of high-risk medical devices who would benefit from advice on their intended clinical development strategies for innovative products are being invited to submit a letter of interest to the European Medicines Agency under a pilot scheme. The deadline for applications within the first round is 15 April.
EMA Expert Advice Pilot Could Be ‘Vital Source Of Guidance’ For SMEs
Ten medical device manufacturers will receive scientific advice from expert panels on their product clinical development strategies under a new European Medicines Agency pilot scheme. But who will it ultimately benefit and what does the scheme entail?
EU MDR: Notified Body Clinical Evidence Expectations Could Spell Trouble For Manufacturers
Detailed guidance documents aim to provide clarity on what constitutes “sufficient” clinical evidence under the new EU Medical Device Regulation. But a void remains between the MDR itself and what notified bodies expect, senior regulatory consultant Søren Underbjerg attests.